SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899866-18-000114
Filing Date
2018-07-12
Accepted
2018-07-12 17:23:37
Documents
2
Period of Report
2018-07-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_153143060154063.html 4  
1 FORM 4 wf-form4_153143060154063.xml 4 3334
2 POA powerofattorneyform4clancy.htm EX-24 3129
  Complete submission text file 0000899866-18-000114.txt   7913
Mailing Address 121 SEAPORT BOULEVARD BOSTON MA 02210
Business Address 121 SEAPORT BOULEVARD BOSTON MA 02210 4752302596
ALEXION PHARMACEUTICALS, INC. (Issuer) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIOGEN IDEC INC. 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142
Business Address
Clancy Paul J (Reporting) CIK: 0001409601 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-27756 | Film No.: 18951081